Methods and systems for treating vulnerable plaque
The invention provides methods and catheter-based delivery systems for treating vulnerable plaque atherosclerotic conditions using lightweight vulnerable plaque shields. Combination catheters are provided that include a selectively deployable occlusion balloon to occlude blood flow and a mechanism for selectively deploying a lightweight vulnerable plaque shield, which is either self-expanding or balloon-deployable, within a blood vessel.
1 . A method of treating a vulnerable plaque condition in a patient, comprising the steps of:
determining the location of a vulnerable plaque in a patient;
advancing a combination occlusion and shield deployment catheter to the location of the vulnerable plaque, wherein the catheter comprises:
an occlusion balloon; and
an unexpanded, self-expanding vulnerable plaque shield, the shield being located proximally along the catheter with respect to the occlusion balloon;
deploying the occlusion balloon to occlude blood flow; and
while blood flow is at least substantially occluded by the deployed occlusion balloon, deploying the self-expanding vulnerable plaque shield so that it at least partially covers the vulnerable plaque.
2 . The method of claim 1 , further comprising the step of:
advancing a guide wire through the vasculature of the patient to the location of the vulnerable plaque; and wherein
the step of advancing the combination occlusion and shield deployment catheter to the location of the vulnerable plaque comprises advancing the catheter along the guide wire to the location of the vulnerable plaque.
3 . The method of claim 1 , further comprising the steps of:
deflating the occlusion balloon; and
withdrawing the catheter from the patient, leaving the vulnerable plaque shield deployed in the patient.
4 . The method of claim 1 , wherein the vulnerable plaque shield is an at least substantially tubular, filament-based prosthesis.
5 . The method of claim 1 , wherein the occlusion balloon is a low-pressure balloon.
6 . A combination occlusion and shield deployment catheter for treating vulnerable plaque conditions, comprising:
a distal end for insertion into a patient's body and a proximal end;
a selectively deployable occlusion balloon capable of occluding blood flow in a blood vessel;
a selectively deployable, vulnerable plaque shield, located proximally along the catheter with respect to the occlusion balloon.
7 . The catheter of claim 6 , wherein the vulnerable plaque shield has a shield wall having cell sizes at least predominantly in the range of 0.038 mm 2 -0.180 mm 2 .
8 . The catheter of claim 7 , wherein the shield wall of the vulnerable plaque shield is an at least substantially braided structure.
9 . The catheter of claim 6 , wherein the vulnerable plaque shield has a shield wall having average cell sizes in the range of about 0.038 mm 2 to about 0.180 mm 2 .
10 . The catheter of claim 9 , wherein the shield wall of the vulnerable plaque shield is at least substantially a braided structure.
11 . The catheter of claim 6 , further comprising at least one radiopaque marker or portion.
12 . The catheter of claim 6 , wherein the occlusion balloon is a low-pressure balloon.
13 . The catheter of claim 6 , wherein the shield is self-expanding.
14 . The catheter of claim 13 , wherein the shield is an at least substantially tubular, filament-based prosthesis.
15 . The catheter of claim 6 , further comprising a protective wing located at or near the proximal edge of the occlusion balloon.
16 . A method of treating a vulnerable plaque condition in a patient, comprising the steps of:
determining the location of a vulnerable plaque in a patient using a low-resolution Raman spectroscopy system;
advancing a combination occlusion and shield deployment catheter to the location of the vulnerable plaque, wherein the catheter comprises:
an occlusion balloon; and
an unexpanded, self-expanding vulnerable plaque shield, the shield being located proximally along the catheter with respect to the occlusion balloon;
deploying the occlusion balloon to occlude blood flow; and
while blood flow is at least substantially occluded by the deployed occlusion balloon, deploying the self-expanding vulnerable plaque shield so that it at least partially covers the vulnerable plaque.
17 . The method of claim 16 , further comprising the steps of:
deflating the occlusion balloon; and
withdrawing the catheter from the patient, leaving the vulnerable plaque shield deployed in the patient.
18 . A method of treating a vulnerable plaque condition in a patient, comprising the following steps:
a step for determining the location of a vulnerable plaque in a patient;
advancing a combination occlusion and shield deployment catheter to the location of the vulnerable plaque, wherein the catheter comprises:
an occlusion balloon; and
an unexpanded, self-expanding vulnerable plaque shield, the shield being located proximally along the catheter with respect to the occlusion balloon;
deploying the occlusion balloon to occlude blood flow; and
while blood flow is at least substantially occluded by the deployed occlusion balloon, deploying the self-expanding vulnerable plaque shield so that it at least partially covers the vulnerable plaque.
19 . A method of treating a vulnerable plaque condition in a patient, comprising the steps of:
determining the location of a vulnerable plaque in a patient;
advancing a combination occlusion and shield deployment catheter to the location of the vulnerable plaque, wherein the catheter comprises:
an occlusion balloon; and
an unexpanded, balloon-expandable vulnerable plaque shield mounted circumferentially about a deployment balloon, the shield being located proximally along the catheter with respect to the occlusion balloon;
deploying the occlusion balloon to occlude blood flow;
while blood flow is at least substantially occluded by the deployed occlusion balloon, deploying the vulnerable plaque shield by expanding the deployment balloon so that the shield at least partially covers the vulnerable plaque.
20 . The method of claim 19 , further comprising the step of:
advancing a guide wire through the vasculature of the patient to the location of the vulnerable plaque; and wherein
the step of advancing the combination occlusion and shield deployment catheter to the location of the vulnerable plaque comprises advancing the catheter along the guide wire to the location of the vulnerable plaque.
21 . The method of claim 19 , further comprising the steps of:
deflating the deployment balloon;
deflating the occlusion balloon; and
withdrawing the catheter from the patient, leaving the vulnerable plaque shield deployed in the patient.
22 . The method of claim 19 , wherein the vulnerable plaque shield is an at least substantially tubular, filament-based prosthesis.
23 . The method of claim 19 , wherein the occlusion balloon is a low-pressure balloon.
24 . The method of claim 19 , wherein the deployment balloon is a low-pressure balloon.
25 . The method of claim 19 , wherein each of the occlusion balloon and the deployment balloon is a low-pressure balloon.
26 . A combination occlusion and shield deployment catheter for treating vulnerable plaque conditions, comprising:
a distal end for insertion into a patient's body and a proximal end;
a selectively deployable occlusion balloon capable of occluding blood flow in a blood vessel;
a selectively balloon-expandable vulnerable plaque shield mounted circumferentially on a deployment balloon, the shield being located proximally along the catheter with respect to the occlusion balloon.
27 . The catheter of claim 26 , wherein the vulnerable plaque shield has a shield wall having cell sizes at least predominantly in the range of 0.038 mm 2 -0.180 mm 2 .
28 . The catheter of claim 26 , wherein the shield wall of the vulnerable plaque shield is at least substantially a braided structure.
29 . The catheter of claim 26 , wherein the vulnerable plaque shield has a shield wall having average cell sizes in the range of about 0.038 mm 2 to about 0.180 mm 2 .
30 . The catheter of claim 29 , wherein the shield wall of the vulnerable plaque shield is a braided structure.
31 . The catheter of claim 26 , further comprising at least one radiopaque marker or portion.
32 . The catheter of claim 26 , wherein the occlusion balloon is a low-pressure balloon.
33 . The catheter of claim 26 , wherein the deployment balloon is a low-pressure balloon.
34 . The catheter of claim 26 , wherein each of the occlusion balloon and the deployment balloon is a low-pressure balloon.
35 . The catheter of claim 26 , further comprising a protective wing located at or near the proximal edge of the occlusion balloon.